Xiangyu Medical(SH:688626) Xin Lang Cai Jing·2026-01-05 10:44Core Viewpoint - The brain-computer interface (BCI) sector has experienced a significant surge, with 29 out of 51 component stocks hitting the daily limit up, and a remarkable 40 stocks showing gains of over 10% on the first trading day of the year [2][15]. Company Performance - Xiangyu Medical (stock code: 688626.SH) achieved a 20% limit up on January 5, closing at 72.6 yuan per share, marking a four-and-a-half-year high [2][4]. - Since December 12, 2022, Xiangyu Medical's stock has increased by 53% over 15 trading days [8][21]. - The stock has shown a cumulative increase of 149.06% since the beginning of the previous year [3][17]. - The total market capitalization of Xiangyu Medical reached 11.6 billion yuan, reflecting a nearly 160% increase compared to 4.5 billion yuan at the beginning of 2025 [9][23]. Institutional Interest - The company has attracted significant institutional attention, receiving visits from 71 institutions in a short span from December 22 to December 29, 2022 [9][24]. - Xiangyu Medical has been the most popular among 48 listed companies in the BCI sector, with 553 institutions participating in its research activities [10][25]. Industry Trends - The BCI sector is shifting from a focus on technological competition to the ability to commercialize products effectively [11][26]. - Xiangyu Medical is concentrating on non-invasive BCI technology for rehabilitation medical applications, while also considering invasive and semi-invasive approaches [11][26]. - The company has established strategic partnerships with over 150 large hospitals and aims to cover 500 top-tier hospitals by the upcoming Spring Festival, expanding to over 1,000 hospitals next year [12][27]. Market Performance - The BCI sector index has risen by 75.33% over the past year, significantly outperforming the Shanghai and Shenzhen 300 index, which increased by 19.89% [13][28]. - Among the 51 listed companies in the BCI sector, 45 have seen stock price increases, with 2 companies experiencing gains between 300% and 200%, and 10 companies between 200% and 100% [13][28].